100 related articles for article (PubMed ID: 6609500)
21. Klebsiella to Salmonella gene transfer within rumen protozoa: implications for antibiotic resistance and rumen defaunation.
McCuddin ZP; Carlson SA; Rasmussen MA; Franklin SK
Vet Microbiol; 2006 May; 114(3-4):275-84. PubMed ID: 16423473
[TBL] [Abstract][Full Text] [Related]
22. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases and strains with extended-spectrum activity of the chromosomal beta-lactamase.
Decré D; Burghoffer B; Gautier V; Petit JC; Arlet G
J Antimicrob Chemother; 2004 Nov; 54(5):881-8. PubMed ID: 15472005
[TBL] [Abstract][Full Text] [Related]
23. [Determination of the isoelectric point of beta-lactamases isolated from 67 Klebsiella oxytoca strains and phenotype behaviour against eight beta-lactam antibiotics].
Chardon H; Pachetti C; Collet L; Bellon O; Lagier E
Pathol Biol (Paris); 1993 Apr; 41(4):343-8. PubMed ID: 8233633
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources.
Podschun R
Zentralbl Hyg Umweltmed; 1990 May; 189(6):527-35. PubMed ID: 2200423
[TBL] [Abstract][Full Text] [Related]
26. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
27. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
28. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic susceptibility, serum response and surface properties of Klebsiella species.
Hostacká A; Klokocníková
Microbios; 2001; 104(408):115-24. PubMed ID: 11297012
[TBL] [Abstract][Full Text] [Related]
30. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and in vitro antimicrobial susceptibilities of community-acquired Klebsiella pneumoniae meningitis in Taiwan.
Lee PY; Chang WN; Lu CH; Lin MW; Cheng BC; Chien CC; Chang CJ; Chang HW
J Antimicrob Chemother; 2003 Apr; 51(4):957-62. PubMed ID: 12654767
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Nathwani D
Int J Antimicrob Agents; 2004 Mar; 23(3):240-6. PubMed ID: 15164964
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
34. Fluoroquinolone resistance in clinical isolates of Klebsiella oxytoca.
Horii T; Osaki M; Muramatsu H
Chemotherapy; 2008; 54(4):323-7. PubMed ID: 18698136
[TBL] [Abstract][Full Text] [Related]
35. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
[TBL] [Abstract][Full Text] [Related]
36. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
[TBL] [Abstract][Full Text] [Related]
38. Serum resistance properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources.
Podschun R; Teske E; Ullmann U
Zentralbl Hyg Umweltmed; 1991 Nov; 192(3):279-85. PubMed ID: 1777008
[TBL] [Abstract][Full Text] [Related]
39. Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.
Wu SW; Dornbusch K; Kronvall G
Antimicrob Agents Chemother; 1999 May; 43(5):1294-7. PubMed ID: 10223957
[TBL] [Abstract][Full Text] [Related]
40. Bases of variation in resistance to beta-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamase.
Gheorghiu R; Yuan M; Hall LM; Livermore DM
J Antimicrob Chemother; 1997 Oct; 40(4):533-41. PubMed ID: 9372423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
